부산대학교 도서관

Lakhani, Nehal J ; Chow, Laura Q M ; Gainor, Justin F ; LoRusso, Patricia ; Lee, Keun-Wook ; Chung, Hyun Cheol ; Lee, Jeeyun ; Bang, Yung-Jue ; Hodi, Frank Stephen ; Kim, Won Seog ; Santana-Davila, Rafael ; Fanning, Philip ; Squifflet, Pierre ; Jin, Feng ; Kuo, Tracy C ; Wan, Hong I ; Pons, Jaume ; Randolph, Sophia S ; Messersmith, Wells A

In The Lancet Oncology December 2021 22(12):1740-1751

Antonia, Scott J ; Borghaei, Hossein ; Ramalingam, Suresh S ; Horn, Leora ; De Castro Carpeño, Javier ; Pluzanski, Adam ; Burgio, Marco A ; Garassino, Marina ; Chow, Laura Q M ; Gettinger, Scott ; Crinò, Lucio ; Planchard, David ; Butts, Charles ; Drilon, Alexander ; Wojcik-Tomaszewska, Joanna ; Otterson, Gregory A ; Agrawal, Shruti ; Li, Ang ; Penrod, John R ; Brahmer, Julie

In The Lancet Oncology October 2019 20(10):1395-1408

Plimack, Elizabeth R ; Bellmunt, Joaquim ; Gupta, Shilpa ; Berger, Raanan ; Chow, Laura Q M ; Juco, Jonathan ; Lunceford, Jared ; Saraf, Sanatan ; Perini, Rodolfo F ; O'Donnell, Peter H

In The Lancet Oncology February 2017 18(2):212-220

Kim, Dong-Wan ; Mehra, Ranee ; Tan, Daniel S W ; Felip, Enriqueta ; Chow, Laura Q M ; Camidge, D Ross ; Vansteenkiste, Johan ; Sharma, Sunil ; De Pas, Tommaso ; Riely, Gregory J ; Solomon, Benjamin J ; Wolf, Jürgen ; Thomas, Michael ; Schuler, Martin ; Liu, Geoffrey ; Santoro, Armando ; Sutradhar, Santosh ; Li, Siyu ; Szczudlo, Tomasz ; Yovine, Alejandro ; Shaw, Alice T

In The Lancet Oncology April 2016 17(4):452-463

Cottrell TR; Queen's University Sinclair Cancer Research Institute, Kingston, Ontario, Canada trc3@queensu.ca.; Lotze MT; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Ali A; Stem Cell Transplant and Cellular Immunotherapy Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, Washington, DC, USA.; Bifulco CB; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.; Capitini CM; University of Wisconsin School of Medicine and Public Health and Carbone Cancer Center, Madison, Wisconsin, USA.; Chow LQM; The University of Texas at Austin, Austin, Texas, USA.; Cillo AR; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Collyar D; Patient Advocates In Research (PAIR), Danville, California, USA.; Cope L; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Deutsch JS; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Dubrovsky G; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Gnjatic S; Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Goh D; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore.; Halabi S; Duke School of Medicine and Duke Cancer Institute, Durham, North Carolina, USA.; Kohanbash G; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Maecker HT; Stanford University School of Medicine, Stanford, California, USA.; Maleki Vareki S; Department of Oncology and Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Mullin S; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Seliger B; Campus Brandenburg an der Havel, Brandenburg Medical School, Halle, Germany.; Taube J; Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Vos W; Radiomics.bio, Liège, Belgium.; Yeong J; Institute of Molecular and Cell Biology (IMCB), Agency of Science, Technology and Research (ASTAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore.; Anderson KG; Department of Microbiology, Immunology and Cancer Biology, Department of Obstetrics and Gynecology, Beirne B. Carter Center for Immunology Research and the University of Virginia Comprehensive Cancer Center, University of Virginia, Charlottesville, Virginia, USA.; Bruno TC; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Tumor Microenvironment Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Chiuzan C; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.; Diaz-Padilla I; GSK Oncology Research Unit, GSK, Baar, Zug, Switzerland.; Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Glitza Oliva IC; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Grandi P; Adze Biotech Inc, Cambridge, Massachusetts, USA.; Hill EG; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.; Hobbs BP; Dell Medical School, The University of Texas, Austin, Texas, USA.; Najjar YG; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Pettit Nassi P; University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA.; Simons VH; Prostate Net, Stanford, North Carolina, USA.; Subudhi SK; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sullivan RJ; Massachusetts General Hospital, Harvard Medical School, Needham, Massachusetts, USA.; Takimoto CH; IGM Biosciences, Mountain View, California, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E; Chow, Laura Q M; Burgio, Marco Angelo; de Castro Carpeno, Javier; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Arén; Chiari, Rita; Butts, Charles; Wójcik-Tomaszewska, Joanna; Coudert, Bruno; Garassino, Marina Chiara; Ready, Neal; Felip, Enriqueta; García, Miriam Alonso; Waterhouse, David; Domine, Manuel; Barlesi, Fabrice

Journal of Clinical Oncology. 3/1/2021, Vol. 39 Issue 7, p723-733. 11p.

New England Journal of Medicine. 1/2/2020, Vol. 382 Issue 1, p60-72. 13p.

Gule-Monroe MK; The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mgule@mdanderson.org.; Calle S; Research Author, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Policeni B; Panel Chair, University of Iowa Hospitals and Clinics, Iowa City, Iowa.; Juliano AF; Panel Vice-Chair, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.; Agarwal M; Froedtert Memorial Lutheran Hospital Medical College of Wisconsin, Milwaukee, Wisconsin.; Chow LQM; University of Texas at Austin, Dell Medical School, Austin, Texas; American Society of Clinical Oncology.; Dubey P; Houston Methodist Hospital, Houston, Texas.; Friedman ER; Houston Methodist Hospital, Houston, Texas.; Hagiwara M; New York University Langone Health, New York, New York.; Hanrahan KD; University of Iowa Hospital, Iowa City, Iowa, Primary care physician.; Jain V; MetroHealth Medical Center, Cleveland, Ohio.; Rath TJ; Mayo Clinic Arizona, Phoenix, Arizona.; Smith RB; Baptist Medical Center, Jacksonville, Florida; American Academy of Otolaryngology-Head and Neck Surgery.; Subramaniam RM; University of Otago, Dunedin, Otepoti, New Zealand; Commission on Nuclear Medicine and Molecular Imaging.; Taheri MR; George Washington University Hospital, Washington, District of Columbia.; Yom SS; University of California, San Francisco, San Francisco, California.; Zander D; University of Colorado Denver, Denver, Colorado.; Burns J; Specialty Chair, Montefiore Medical Center, Bronx, New York.

Publisher: Elsevier Country of Publication: United States NLM ID: 101190326 Publication Model: Print Cited Medium: Internet ISSN: 1558-349X (Electronic) Linking ISSN: 15461440 NLM ISO Abbreviation: J Am Coll Radiol Subsets: MEDLINE

Chow, Laura; Smith, David; Tan, Antoinette; Denlinger, Crystal; Wang, Ding; Shepard, Dale; Chaudhary, Archana; Lin, Yong; Gao, Ling; Chow, Laura Q M; Smith, David C; Tan, Antoinette R; Denlinger, Crystal S; Shepard, Dale R

Cancer Chemotherapy & Pharmacology. Aug2016, Vol. 78 Issue 2, p433-441. 9p.

Pfister DG; Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Worden FP; Division of Medical Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Weiss J; Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.; Mehra R; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Chow LQM; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.; The University of Texas at Austin, Dell Medical School, Texas, Austin, USA.; Liu SV; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.; Kang H; Department of Medical Oncology, Johns Hopkins University, Baltimore, Maryland, USA.; University of California, San Francisco, California, USA.; Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Wirth LJ; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Sukari A; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.; Massarelli E; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ayers M; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Albright A; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Webber AL; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Mogg R; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Lunceford J; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Huang L; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Cristescu R; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Cheng J; Department of Medical Oncology, Merck & Co., Inc., Rahway, New Jersey, USA.; Bristol Myers Squibb, Philadelphia, Pennsylvania, USA.; Seiwert TY; Section of Hematology-Oncology, University of Chicago Department of Medicine, Chicago, Illinois, USA.; Johns Hopkins University, Baltimore, Maryland, USA.; Bauml JM; Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Janssen Research and Development, Philadelphia, Pennsylvania, USA.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

Shaw, Alice T; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y; Goldwasser, Meredith; Boral, Anthony L

New England Journal of Medicine. 3/27/2014, Vol. 370 Issue 13, p1189-1197. 9p.

Chow LQM; University of Washington, Seattle, Washington and University of Texas at Austin, Dell Medical School, Department of Oncology, Austin, Texas.; Barlesi F; Aix-Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France.; Bertino EM; The Ohio State University Comprehensive Cancer Centre, Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, Ohio.; van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Wakelee HA; Stanford University, Stanford, California.; Wen PY; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Chiu CH; Department of Chest Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.; Orlov S; State Pavlov Medical University, St. Petersburg, Russia.; Chiari R; Department of Oncology, AULSS6 Euganea, Padova, Italy.; Majem M; Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.; McKeage M; University of Auckland, Auckland, New Zealand.; Yu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Garrido P; Department of Medical Oncology, Hospital Universitario Ramon Y Cajal, Madrid, Spain.; Hurtado FK; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.; Arratia PC; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.; Song Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.; Branle F; Novartis Pharma AG, Basel, Switzerland.; Shi M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.; Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Kennedy LC; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. laura.kennedy@vumc.org.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. laura.kennedy@vumc.org.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. laura.kennedy@vumc.org.; Lu J; Divison of Epidemiology and Biostatistics, University of Illinois, Chicago, IL, USA.; Biostatistics Shared Resource, University of Illinois Cancer Center, Chicago, IL, USA.; Kuehn S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Ramirez AB; RareCyte, Inc., Seattle, WA, USA.; Lo E; RareCyte, Inc., Seattle, WA, USA.; Sun Y; RareCyte, Inc., Seattle, WA, USA.; U'Ren L; RareCyte, Inc., Seattle, WA, USA.; Chow LQM; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Department of Oncology, University of Texas at Austin, Austin, TX, USA.; Chen Z; Divison of Epidemiology and Biostatistics, University of Illinois, Chicago, IL, USA.; Biostatistics Shared Resource, University of Illinois Cancer Center, Chicago, IL, USA.; Grivas P; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Kaldjian EP; RareCyte, Inc., Seattle, WA, USA.; Gadi VK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Illinois, Chicago, IL, USA.

Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Hufnagel S; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, United States.; Xu H; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, United States.; Sahakijpijarn S; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, United States.; Moon C; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, United States.; Chow LQM; Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, United States.; Williams Iii RO; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, United States. Electronic address: bill.williams@austin.utexas.edu.; Cui Z; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, United States. Electronic address: zhengrong.cui@austin.utexas.edu.

Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

Haddad RI; Department of Medical Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA Robert_Haddad@dfci.harvard.edu.; Seiwert TY; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA.; Chow LQM; Department of Medicine, University of Washington, Seattle, Washington, USA.; Gupta S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.; Weiss J; Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, North Carolina, USA.; Gluck I; Department of Oncology, Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel.; Eder JP; Department of Medicine, Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.; Burtness B; Division of Medical Oncology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.; Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Kang H; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland, USA.; Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.; Albright A; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Mogg R; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Ayers M; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Huang L; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Lunceford J; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Cristescu R; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Cheng J; Merck & Co., Inc, Kenilworth, New Jersey, USA.; Mehra R; Department of Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Garon EB; Department of Medicine, David Geffen School of Medicine at UCLA, Santa Monica, California. egaron@mednet.ucla.edu.; Spira AI; Department of Medicine, Virginia Cancer Specialists, Fairfax, Virginia.; Johnson M; Sarah Cannon Research Institute, Nashville, Tennessee.; Bazhenova L; Department of Medicine, UC San Diego, San Diego, California.; Leach J; Allina Health Virginia Piper Cancer Institute, Minneapolis, Minnesota.; Cummings AL; Department of Medicine, David Geffen School of Medicine at UCLA, Santa Monica, California.; Candia A; Dynavax Technologies Corporation, Emeryville, California.; Coffman RL; Dynavax Technologies Corporation, Emeryville, California.; Janatpour MJ; Dynavax Technologies Corporation, Emeryville, California.; Janssen R; Dynavax Technologies Corporation, Emeryville, California.; Gamelin E; Dynavax Technologies Corporation, Emeryville, California.; Chow LQM; Department of Medicine, University of Washington, Seattle, Washington.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Creelan BC; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB-1, Tampa, FL, 33612, USA. Ben.Creelan@moffitt.org.; Yeh TC; Translational Medicine, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.; Nogami N; Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto-cho, Matsuyama City, 791-0280, Japan.; Kim DW; Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.; Chow LQM; Department of Medicine, Division of Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, 98109, USA.; Kanda S; Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, Nagano, 390-8621, Japan.; Taylor R; Oncology, AstraZeneca, Academy House, 132-136 Hills Road, Cambridge, CB2 8PA, UK.; Tang W; Clinical Pharmacology and Safety Assessment, AstraZeneca, One Medimmune Way, 101 ORD, 2001D, Gaithersburg, MD, 20878, USA.; Tang M; Clinical Pharmacology and Safety Assessment, AstraZeneca, One Medimmune Way, 101 ORD, 2001D, Gaithersburg, MD, 20878, USA.; Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Darwin Building, Unit 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.; Roudier MP; Translational Medicine, Oncology R&D, AstraZeneca, Darwin Building, Unit 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.; Marotti M; Oncology, AstraZeneca, Academy House, 132-136 Hills Road, Cambridge, CB2 8PA, UK.; Gibbons DL; Departments of Thoracic/Head and Neck Medical Oncology and Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Hellmann MD; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.; Gettinger S; Yale Cancer Center, New Haven, Connecticut, USA.; Chow LQM; University of Texas at Austin, Austin, Texas, USA.; Gordon M; HonorHealth Research Institute, Scottsdale, Arizona, USA.; Awad MM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cha E; Genentech, Inc., South San Francisco, California, USA.; Gong X; Incyte Corporation, Wilmington, Delaware, USA.; Zhou G; Incyte Corporation, Wilmington, Delaware, USA.; Walker C; Incyte Corporation, Wilmington, Delaware, USA.; Leopold L; Incyte Corporation, Wilmington, Delaware, USA.; Heist RS; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Al Achkar M; Family Medicine, University of Washington, Seattle, Washington, USA alachkar@uw.edu.; Marchand L; Family Medicine, University of Washington, Seattle, Washington, USA.; Thompson M; Family Medicine, University of Washington, Seattle, Washington, USA.; Chow LQM; Department of Oncology, University of Texas at Austin, Dell Medical School, Austin, Texas, USA.; Revere D; School of Public Health, University of Washington, Seattle, Washington, USA.; Baldwin LM; Family Medicine, University of Washington, Seattle, Washington, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

Rodriguez CP; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington. rodrigcr@uw.edu.; Wu QV; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Voutsinas J; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Fromm JR; Department of Laboratory Medicine, University of Washington, Seattle, Washington.; Jiang X; Department of Surgery, University of Washington, Seattle, Washington.; Pillarisetty VG; Department of Surgery, University of Washington, Seattle, Washington.; Lee SM; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Santana-Davila R; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Goulart B; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Baik CS; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Chow LQM; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Eaton K; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Martins R; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE